公司概覽
業務類別 Biotechnology
業務概覽 Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.
公司地址 3901 Barrett Drive, P.O. Box 19469, Suite 300, Raleigh, NC, USA, 27609
電話號碼 +1 919 659-5677
傳真號碼 --
公司網頁 https://www.vogenx.com
員工數量 5
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Steven R. Delmar Director, Corporate Secretary and Chief Financial Officer -- 29/07/2026
Mr. James Green Chairman of the Board, President and Chief Executive Officer -- 29/07/2026
Dr. William Wilkison, PhD Director and Chief Scientific Officer -- 29/07/2026
Mr. Richard Gorman Chief Commercial Officer -- 09/10/2026
 
董事會成員
董事會 職務 更新日期
Mr. Steven R. Delmar Director, Corporate Secretary and Chief Financial Officer 29/07/2026
Mr. Timothy Boris Independent Director 29/07/2026
Mr. James Green Chairman of the Board, President and Chief Executive Officer 29/07/2026
Dr. William Wilkison, PhD Director and Chief Scientific Officer 29/07/2026
Mr. Peter Pieraccini Independent Director 29/07/2026
Mr. Kenneth John Toombs Independent Director 22/09/2026
 
所屬ETF (更新日期: 17/10/2026 02:53)
代號 名稱 佔比% ▼ 持有日期
VTWOVanguard Russell 2000 ETF0.04%30/09/2026
VTWGVanguard Russell 2000 Growth ETF0.004%30/09/2026
VTWVVanguard Russell 2000 Value ETF0.001%30/09/2026
VTHRVanguard Russell 3000 ETF0.001%30/09/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.